These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Whole body positron emission tomography imaging of activated lymphoid tissues during acute simian-human immunodeficiency virus 89.6PD infection in rhesus macaques. Wallace M; Pyzalski R; Horejsh D; Brown C; Djavani M; Lu Y; Hanson JM; Mitchen JL; Perlman SB; Pauza CD Virology; 2000 Sep; 274(2):255-61. PubMed ID: 10964769 [TBL] [Abstract][Full Text] [Related]
3. Detecting metastatic neck lymph nodes in papillary thyroid carcinoma by 18F-2-deoxyglucose positron emission tomography and Tc-99m tetrofosmin single photon emission computed tomography. Wu YJ; Wu HS; Yen RF; Shen YY; Kao CH Anticancer Res; 2003; 23(3C):2973-6. PubMed ID: 12926147 [TBL] [Abstract][Full Text] [Related]
4. Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease. Jerusalem G; Beguin Y; Fassotte MF; Najjar F; Paulus P; Rigo P; Fillet G Haematologica; 2001 Mar; 86(3):266-73. PubMed ID: 11255273 [TBL] [Abstract][Full Text] [Related]
5. Anatomical loci of HIV-associated immune activation and association with viraemia. Iyengar S; Chin B; Margolick JB; Sabundayo BP; Schwartz DH Lancet; 2003 Sep; 362(9388):945-50. PubMed ID: 14511927 [TBL] [Abstract][Full Text] [Related]
6. Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging. Moog F; Bangerter M; Diederichs CG; Guhlmann A; Kotzerke J; Merkle E; Kolokythas O; Herrmann F; Reske SN Radiology; 1997 Jun; 203(3):795-800. PubMed ID: 9169707 [TBL] [Abstract][Full Text] [Related]
7. Lymph node metastasis of squamous cell carcinoma from an unknown primary in the upper and middle neck: Impact of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography. Deron PB; Bonte KM; Vermeersch HF; Van de Wiele C Cancer Biother Radiopharm; 2011 Jun; 26(3):331-4. PubMed ID: 21711095 [TBL] [Abstract][Full Text] [Related]
8. Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation. Brust D; Polis M; Davey R; Hahn B; Bacharach S; Whatley M; Fauci AS; Carrasquillo JA AIDS; 2006 Feb; 20(4):495-503. PubMed ID: 16470113 [TBL] [Abstract][Full Text] [Related]
9. Combined FDG and [F-18]fluoride whole-body PET: a feasible two-in-one approach to cancer imaging? Hoegerle S; Juengling F; Otte A; Altehoefer C; Moser EA; Nitzsche EU Radiology; 1998 Oct; 209(1):253-8. PubMed ID: 9769840 [TBL] [Abstract][Full Text] [Related]
11. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. Laubenbacher C; Saumweber D; Wagner-Manslau C; Kau RJ; Herz M; Avril N; Ziegler S; Kruschke C; Arnold W; Schwaiger M J Nucl Med; 1995 Oct; 36(10):1747-57. PubMed ID: 7562038 [TBL] [Abstract][Full Text] [Related]
12. Immune reconstitution inflammatory syndrome due to Mycobacterium avium complex successfully followed up using 18 F-fluorodeoxyglucose positron emission tomography-computed tomography in a patient with human immunodeficiency virus infection: A case report. Namkoong H; Fujiwara H; Ishii M; Yagi K; Haraguchi M; Matsusaka M; Suzuki S; Asakura T; Asami T; Saito F; Fukunaga K; Tasaka S; Betsuyaku T; Hasegawa N BMC Med Imaging; 2015 Jul; 15():24. PubMed ID: 26187282 [TBL] [Abstract][Full Text] [Related]
13. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer? Schaefferkoetter JD; Carlson ER; Heidel RE J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746 [TBL] [Abstract][Full Text] [Related]
14. Value of whole body 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent cervical cancer. Sun SS; Chen TC; Yen RF; Shen YY; Changlai SP; Kao A Anticancer Res; 2001; 21(4B):2957-61. PubMed ID: 11712793 [TBL] [Abstract][Full Text] [Related]
15. Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma. Kurli M; Reddy S; Tena LB; Pavlick AC; Finger PT Am J Ophthalmol; 2005 Aug; 140(2):193-9. PubMed ID: 15992753 [TBL] [Abstract][Full Text] [Related]
16. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Kato H; Kuwano H; Nakajima M; Miyazaki T; Yoshikawa M; Ojima H; Tsukada K; Oriuchi N; Inoue T; Endo K Cancer; 2002 Feb; 94(4):921-8. PubMed ID: 11920459 [TBL] [Abstract][Full Text] [Related]
17. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma. Trojan J; Schroeder O; Raedle J; Baum RP; Herrmann G; Jacobi V; Zeuzem S Am J Gastroenterol; 1999 Nov; 94(11):3314-9. PubMed ID: 10566736 [TBL] [Abstract][Full Text] [Related]
18. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma. Kostakoglu L; Leonard JP; Kuji I; Coleman M; Vallabhajosula S; Goldsmith SJ Cancer; 2002 Feb; 94(4):879-88. PubMed ID: 11920454 [TBL] [Abstract][Full Text] [Related]
19. Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy. Haberkorn U; Strauss LG; Dimitrakopoulou A; Seiffert E; Oberdorfer F; Ziegler S; Reisser C; Doll J; Helus F; van Kaick G J Nucl Med; 1993 Jan; 34(1):12-7. PubMed ID: 8418251 [TBL] [Abstract][Full Text] [Related]
20. Feasibility of a short acquisition protocol for whole-body positron emission tomography with fluorine-18 fluorodeoxyglucose. Paul AK; Tatsumi M; Fujino K; Hashikawa K; Nishimura T Eur J Nucl Med; 2001 Nov; 28(11):1697-701. PubMed ID: 11702113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]